Polymorphism of methylenetetrahydrofolate reductase gene and chromosomal abnormalities among childbearing age women of different nationalities in Xinjiang Uygur Autonomous Region

doi:10.3877/cma.j.issn.1673-5250.2022.05.015

Objective

To investigate correlation between embryonic abortion(EA) and methylenetetrahydrofolate reductase (MTHFR) gene and methionine synthase reductase (MTRR) gene polymorphisms and chromosomal abnormalities in women of childbearing age in Xinjiang.

Methods

From May 2017 to January 2020, a total of 200 women of childbearing age who were treated at the Eighth People′s Hospital of Xinjiang Uygur Autonomous Region for EA were selected into this study. According to different nationalities, they were divided into Han group (n=100) and Uygur group (n=100). The MTHFR gene C677T, MTHFR gene A1298C and MTRR gene A66G were detected by real-time fluorescence quantitative polymerase chain reaction (qRT-PCR) technology, and genotyping and chromosome abnormality were analyzed. The study met requirements of Helsinki Declaration of World Medical Association newly revised in 2013. Informed consent was obtained from each participate.

Results

①In the Han group, the percentage of CC and CT genotypes at the C677T locus of MTHFR gene (18.0%, 36.0%) and the percentage of AA genotypes at the A66G locus of MTRR gene (38.0%) were lower than those in the Uygur group (38.0%, 56.0%, 65.0%), and the differences were statistically significant when compared between two groups (χ²=9.92, 8.05, 14.59; P<0.05). And in the Han group, the percentage of TT genotype at the C677T locus of the MTHFR gene (46.0%) and the percentage of AG and GG genotypes at the A66G locus of the MTRR gene (40.0%, 22.0%) were higher than those in the Uygur group (6.0%, 33.0%, 2.0%), and the differences were also statistically significant when compared between groups (χ²=41.58, 14.59, 6.71, P<0.05). ②The proportions of C allele at the C677T locus of MTHFR gene (35.0%) and A allele at the A66G locus of MTRR gene (68.0%) in the Han group were lower than those in the Uygur group (66.0% and 82.0%), and the difference were statistically significant (P<0.05) when comparing between two groups; the proportions of T allele at the C677T locus of MTHFR gene and the G allele at the A66G locus of MTRR gene in the Han group were higher than those in the Uygur group, and the differences were also statistically significant (P<0.05) when comparing between two groups. The distribution of G alleles at the C677T locus of the MTHFR gene and the A66G locus of the MTRR gene in the Han group were higher than those in the Uygur group, and the differences were statistically significant (P<0.05) when comparing between two groups. ③The incidence of chromosomal abnormalities in 200 patients was 27.5% (45/200). Spearman rank correlation analysis showed a positive correlation between the incidence of chromosomal abnormalities and the expression of MTHFR gene C677T and MTRR gene A66G in patients with EA (r_s=0.625, P=0.031; r_s=0.784, P=0.022).

Conclusions

The polymorphism of MTHFR gene in women of childbearing age in Xinjiang is widely distributed, and there is a certain correlation with chromosome abnormality.

Key words: Embryo abortion, Methylenetetrahydrofolate reductase, Methionine synthase reductase, Gene frequency, Alleles, Chromosome aberrations, Xinjiang region, Women

表1 　MTHFR基因C677T、A1298C位点和MTRR基因A66G位点的引物序列

引物类型	引物序列	长度(bp)
β-actin	正向引物：5′-GCTGAGTCCTCTTGCTGTGCTC-3′	91
	反向引物：5′-GTACCTGGAGGCTTGGCATGAC-3′
MTHFR基因C677T位点	正向引物：5′- GGAGCGAGATCCCTCCAAAAT-3′	73
	反向引物：5′-GGCTGTTGTCATACTTCTCATGG-3′
MTHFR基因A1298C位点	正向引物：5′-CAGGATGCAGCAGGTGGAAGC-3′	84
	反向引物：5′-TGCTCCAGGCTGTAGTCTGTGG-3′
MTRR基因A66G位点	正向引物：5′-AGGTTCCTCAGCAGATCATTCTC-3′	69
	反向引物：5′-GAGCGGCATTCTGAGGTCTTAC-3′

表1 　MTHFR基因C677T、A1298C位点和MTRR基因A66G位点的引物序列

引物类型	引物序列	长度(bp)
β-actin	正向引物：5′-GCTGAGTCCTCTTGCTGTGCTC-3′	91
	反向引物：5′-GTACCTGGAGGCTTGGCATGAC-3′
MTHFR基因C677T位点	正向引物：5′- GGAGCGAGATCCCTCCAAAAT-3′	73
	反向引物：5′-GGCTGTTGTCATACTTCTCATGG-3′
MTHFR基因A1298C位点	正向引物：5′-CAGGATGCAGCAGGTGGAAGC-3′	84
	反向引物：5′-TGCTCCAGGCTGTAGTCTGTGG-3′
MTRR基因A66G位点	正向引物：5′-AGGTTCCTCAGCAGATCATTCTC-3′	69
	反向引物：5′-GAGCGGCATTCTGAGGTCTTAC-3′

表2 2组EA患者一般临床资料比较

组别	例数	年龄(岁，±s)	体重(kg，±s)	既往病史[例数(%)]
组别	例数	年龄(岁，±s)	体重(kg，±s)	2型糖尿病	原发性高血压疾病	高脂血症
汉族组	100	33.5±4.4	71.4±5.3	3(3.0)	2(2.0)	5(5.0)
维吾尔族组	100	33.8±4.8	71.8±5.5	4(4.0)	5(5.0)	7(7.0)
统计量		t＝0.46	t＝0.52	χ²<0.01^a	χ²＝0.59	χ²＝0.09
P值		0.646	0.601	>0.999	0.663	0.766

表2 2组EA患者一般临床资料比较

组别	例数	年龄(岁，±s)	体重(kg，±s)	既往病史[例数(%)]
组别	例数	年龄(岁，±s)	体重(kg，±s)	2型糖尿病	原发性高血压疾病	高脂血症
汉族组	100	33.5±4.4	71.4±5.3	3(3.0)	2(2.0)	5(5.0)
维吾尔族组	100	33.8±4.8	71.8±5.5	4(4.0)	5(5.0)	7(7.0)
统计量		t＝0.46	t＝0.52	χ²<0.01^a	χ²＝0.59	χ²＝0.09
P值		0.646	0.601	>0.999	0.663	0.766

表3 2组EA患者MTHFR、MTRR基因型分布比较[例数(%)]

组别	例数	MTHFR基因C677T位点			MTHFR基因A1298C位点			MTRR基因A66G位点
组别	例数	CC	TT	CT	AA	AG	GG	AA	AG	GG
汉族组	100	18(18.0)	46(46.0)	36(36.0)	75(75.0)	20(20.0)	5(5.0)	38(38.0)	40(40.0)	22(22.0)
维吾尔族组	100	38(38.0)	6(6.0)	56(56.0)	76(86.0)	21(21.0)	3(3.0)	65(65.0)	33(33.0)	2(2.0)
χ²值		9.92	41.58	8.05	0.03	0.03	0.52	14.59	0.19	6.71
P值		0.001	<0.001	0.005	0.869	0.861	0.470	<0.001	0.663	0.025

表3 2组EA患者MTHFR、MTRR基因型分布比较[例数(%)]

组别	例数	MTHFR基因C677T位点			MTHFR基因A1298C位点			MTRR基因A66G位点
组别	例数	CC	TT	CT	AA	AG	GG	AA	AG	GG
汉族组	100	18(18.0)	46(46.0)	36(36.0)	75(75.0)	20(20.0)	5(5.0)	38(38.0)	40(40.0)	22(22.0)
维吾尔族组	100	38(38.0)	6(6.0)	56(56.0)	76(86.0)	21(21.0)	3(3.0)	65(65.0)	33(33.0)	2(2.0)
χ²值		9.92	41.58	8.05	0.03	0.03	0.52	14.59	0.19	6.71
P值		0.001	<0.001	0.005	0.869	0.861	0.470	<0.001	0.663	0.025

表4 2组不同风险等级EA患者的年龄分布[例数(%)]

组别		25~29岁	30~35岁	36~40岁	41~46岁	>46岁	合计
维吾尔族组
	无风险	0(0)	7(36.8)	8(42.1)	4(21.0)	0(0)	19(19.0)
	低风险	3(5.9)	15(29.4)	19(37.2)	11(21.6)	3(5.9)	51(51.0)
	中风险	4(14.8)	6(22.2)	9(33.3)	6(22.2)	2(7.4)	27(27.0)
	高风险	0(0)	0(0)	0(0)	0(0)	1(1.0)	3(3.0)
	合计	7(7.0)	30(30.0)	36(36.0)	21(21.0)	6(6.0)	100(100.0)
汉族组
	无风险	3(25.0)	3(25.0)	5(41.7)	1(8.3)	0(0)	12(12.0)
	低风险	6(10.3)	24(41.4)	15(25.9)	10(17.2)	3(5.2)	58(58.0)
	中风险	5(20.0)	9(36.0)	9(36.0)	1(4.0)	1(4.0)	25(25.0)
	高风险	3(60.0)	1(20.0)	1(20.0)	0(0)	0(0)	5(5.0)
	合计	17(17.0)	37(37.0)	30(30.0)	12(12.0)	4(4.0)	100(100.0)

表4 2组不同风险等级EA患者的年龄分布[例数(%)]

组别		25~29岁	30~35岁	36~40岁	41~46岁	>46岁	合计
维吾尔族组
	无风险	0(0)	7(36.8)	8(42.1)	4(21.0)	0(0)	19(19.0)
	低风险	3(5.9)	15(29.4)	19(37.2)	11(21.6)	3(5.9)	51(51.0)
	中风险	4(14.8)	6(22.2)	9(33.3)	6(22.2)	2(7.4)	27(27.0)
	高风险	0(0)	0(0)	0(0)	0(0)	1(1.0)	3(3.0)
	合计	7(7.0)	30(30.0)	36(36.0)	21(21.0)	6(6.0)	100(100.0)
汉族组
	无风险	3(25.0)	3(25.0)	5(41.7)	1(8.3)	0(0)	12(12.0)
	低风险	6(10.3)	24(41.4)	15(25.9)	10(17.2)	3(5.2)	58(58.0)
	中风险	5(20.0)	9(36.0)	9(36.0)	1(4.0)	1(4.0)	25(25.0)
	高风险	3(60.0)	1(20.0)	1(20.0)	0(0)	0(0)	5(5.0)
	合计	17(17.0)	37(37.0)	30(30.0)	12(12.0)	4(4.0)	100(100.0)

表5 2组EA患者MTHFR、MTRR基因型等位基因分布频率比较[例数(%)]

组别	例数	MTHFR基因C677T位点		MTHFR基因A1298C位点		MTRR基因A66G位点
组别	例数	C	T	A	G	A	G
汉族组	100	35(35.0)	65(65.0)	88(88.0)	12(12.0)	68(68.0)	32(32.0)
维吾尔族组	100	66(66.0)	34(34.0)	87(87.0)	13(13.0)	82(82.0)	18(18.0)
χ²值		19.22		0.05		5.23
P值		<0.005		0.830		0.022

表5 2组EA患者MTHFR、MTRR基因型等位基因分布频率比较[例数(%)]

组别	例数	MTHFR基因C677T位点		MTHFR基因A1298C位点		MTRR基因A66G位点
组别	例数	C	T	A	G	A	G
汉族组	100	35(35.0)	65(65.0)	88(88.0)	12(12.0)	68(68.0)	32(32.0)
维吾尔族组	100	66(66.0)	34(34.0)	87(87.0)	13(13.0)	82(82.0)	18(18.0)
χ²值		19.22		0.05		5.23
P值		<0.005		0.830		0.022

[1]	梁玲芝，许美芬，陈贤君，等. 不良妊娠结局患者和正常人群亚甲基四氢叶酸还原酶基因多态性的比较[J]. 中国卫生检验杂志，2018, 28(15): 1862-1864, 1867.
[2]	程世亮，戴永刚，刘新风，等. 亚甲基四氢叶酸还原酶基因多态性及血浆同型半胱氨酸与高血压合并缺血性脑卒中的相关性研究[J].山西医药杂志，2019, 48(3): 360-362. DOI: 10.3969/j.issn.0253-9926.2019.03.039.
[3]	Bergantini A, Abplanalp MJ, Pokhilko P, et al. A combined experimental and theoretical study on the formation of interstellar propylene oxide (CH₃CHCH₂O)-A chiral molecule[J]. Astrophys J，2018，860(2):108.
[4]	张俊．亚甲基四氢叶酸还原酶基因多态性及同型半胱氨酸与心血管疾病相关性研究进展[J].中国心血管病研究，2018，16(12):1065-1068,1094. DOI: 10.3969/j.issn.1672-5301.2018.12.003.
[5]	席晓娥，鲁衍强，付敏，等. 新疆阿克苏地区汉族和维吾尔族女性5，10-亚甲基四氢叶酸还原酶、甲硫氨酸合成酶还原酶基因多态性分布研究[J].中国妇幼保健，2019, 34(6): 1313-1316.
[6]	周永俪，王小林，陈轩，等. 社区人群亚甲基四氢叶酸还原酶基因多态性与颅内动脉粥样硬化性狭窄的相关性研究[J].重庆医科大学学报，2018, 43(8): 1030-1034. DOI: 10.13406/j.cnki.cyxb.001736.
[7]	Jamali Z, Siddiqui AA, Jamali D, et al. Correlation of early and late cord clamping time with hematological variables: an observation study focusing on the neonatal outcomes[J]. Symbiosis，2018，4(1):1-5.
[8]	张萍，万萍，张忠东，等. 亚甲基四氢叶酸还原酶基因多态性与高同型半胱氨酸血症、高脂血症及代谢综合征的相关性研究[J].实用临床医药杂志，2018, 22(21): 23-26. DOI: 10.7619/jcmp.201821007.
[9]	莫亚虹，许琼军，李立康. 海南省女性亚甲基四氢叶酸还原酶基因多态性分布特征研究[J]. 现代预防医学，2018, 45(21): 3899-3902.
[10]	曹云，周晓，张晓艳，等. 陕西省延安地区育龄女性MTHFR基因多态性和国内多地区相关报道比较分析[J].现代检验医学杂志，2019, 34(1): 62-66. DOI: 10.3969/j.issn.1671-7414.2019.01.016.
[11]	孔思雅，党旖旎，张国新. 叶酸预防慢性萎缩性胃炎癌变的研究进展[J].中华消化杂志，2020, 40(1): 66-68. DOI: 10.3760/cma.j.issn.0254-1432.2020.01.016.
[12]	Phillips ML. Abnormal sensitization of neural and behavioral responses to socially relevant images in individuals with borderline personality disorder: implications for guiding more effective targeting of treatments[J]. Am J Psychiatry, 2018, 175(7): 593-595. DOI: 10.1176/appi.ajp.2018.18040435.
[13]	何霞，姚平立，吴宇，等. 亚甲基四氢叶酸还原酶基因多态性与大剂量甲氨蝶呤不良反应的相关性研究[J].实用医院临床杂志，2019，16(2):8-11. DOI: 10.3969/j.issn.1672-6170.2019.02.003.
[14]	安芳，赵季红，王静，等. 亚甲基四氢叶酸还原酶基因多态性与老年高血压伴高同型半胱氨酸血症及颈动脉硬化的相关性研究[J].中华老年心脑血管病杂志，2018, 20(10): 1092-1094. DOI: 10.3969/j.issn.1009-0126.2018.10.021.
[15]	Zhang Y, He X, Xiong X, et al. The association between maternal methylenetetrahydrofolate reductase C677T and A1298C polymorphism and birth defects and adverse pregnancy outcomes[J]. Prenat Diagn, 2019, 39(1): 3-9. DOI: 10.1002/pd.5396.
[16]	冯婉琴，马颖. 亚甲基四氢叶酸还原酶基因多态性与妇科疾病相关性的研究进展[J].实用医学杂志，2019, 35(10): 1677-1680. DOI: 10.3969/j.issn.1006-5725.2019.10.033.
[17]	李杰，李转转，张吉才. 十堰地区女性人群亚甲基四氢叶酸还原酶基因多态性分析[J].中华医学遗传学杂志，2018, 35(4): 572-576. DOI: 10.3760/cma.j.issn.1003-9406.2018.04.025.
[18]	田进海，吴京，杨萍，等. 银川回族人群亚甲基四氢叶酸还原酶基因多态性与高血压和同型半胱氨酸水平的相关性[J].中华高血压杂志，2018，26(10):947-952.
[19]	Yi H, Zhou C, Hepburn DM, et al. Diagnosis of abnormal temperature rise observed on a 275 kV oil-filled cable surface: a case study[J]. IEEE Transactions Dielectr Electr Insul, 2019, 26(2): 547-553.
[20]	李乾，常亮，刘平，等. 母胎亚甲基四氢叶酸还原酶基因C677T多态性与不明原因习惯性流产发生风险的相关性研究[J].生殖医学杂志，2018，27(10):981-985. DOI: 10.3969/j.issn.1004-3845.2018.10.011.

[1]	Lu Wang, Yang Fan. Advances in endometrial cancer-related biomarker research[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 511-516.
[2]	Ling Wei, Hui Li, Yi Chen. Current research status on colonization or infection and mother-to-child transmission of extended-spectrum β-lactamase-producing Enterobacteriaceae in pregnant and post-partum women[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 517-521.
[3]	Dan Luo, Weimin Kong, Shuning Chen, Xiaoling Zhao, Yunkai Xie. Differences in epithelial mesenchymal transition-related biological markers between in-situ and ectopic endometrial epithelial cells in endometriosis patients[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 530-539.
[4]	Tiantian Chen, Xiaodong Wang, Haiyan Yu. Pregnancy outcome of twin pregnancy with Gitelman syndrome: a case report and literature review[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 559-568.
[5]	Xiaoqing Ju, Yunjie Jin, Xiaoyan Wang. Influencing factors of uterine rupture during vaginal delivery in patients with scarred uterus after cesarean section[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 575-581.
[6]	Beibei Wang, Qixiu Dong, Hongyan Xi, Qingyun Yu, Lijun Zhang, Guang Shi. Analysis of influencing factors of medical abortion failure of pregnant women in early pregnancy and construction of related prediction model and its predictive value for medical abortion success[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 588-594.
[7]	Xu Chen, Yuru Zhan, Chunhua Wang. Clinical value of ABO blood group combined with thyroid function in prediction of gestational diabetes mellitus[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 604-610.
[8]	Mengling Zhou, Zhiwei Xue, Shu Zhou. Changes in size of uterine myoma during pregnancy and its association with adverse pregnancy outcomes[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 611-615.
[9]	Chenxi Ran, Rufei Shen, Mingyu Liao, Qian Liao, Ling Zhou, Yuling Zhang, Min Long. Treatment and management of pituitary tumor during pregnancy[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(04): 487-491.
[10]	Xingchen Liu, Juan Liu, Baobao Wei, Jie Liu, Hui Liu. Correlation analysis of abnormal expression of XIAP and XAF1 with ovarian cancer[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(04): 419-427.
[11]	Ying Chen, Yanli Chen. Causes of heart rate variability and perinatal outcomes in elderly pregnant women[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(03): 295-301.
[12]	Danyan Feng, Xiaohui Cao, Yuxia Shi. Effect of serum adiponectin and placental leucine aminopeptidase levels on pregnancy outcome in pregnant women with gestational diabetes mellitus[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(03): 302-308.
[13]	Yijun Yang, Wen Dong, Xiaoping Liu, Can Shi, Lei Zhang, jin Gu, Mi Gong, Fu Hua. Efficacy of laparoscopic folding suture combined with hysteroscopic iverticulum incision in the treatment of cesarean scar diverticulum[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(03): 330-337.
[14]	Hongqin Gao, Chen Chen, Ruike Lu, Xiaoyu Wang, Min Zhang, Shaohua Li, Lilan Hao, Xincheng Huang, Lingyao Guan, Yunhong Zhang. Impact of vulvovaginal candidiasis on vaginal-cervical microbiota in women[J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(06): 720-725.
[15]	Xueyun Liu, Ying Fan, Aijun Yao, Shengmiao Zhang, Yani Lv, Bingqing Zhang, Xiaoyu Zhang, Heng. Liu. Effects of individualized whole-course nursing intervention based on WeChat mini program on pregnancy weight and delivery outcome[J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(04): 455-460.

Viewed

Full text

Abstract

Please choose a citation manager

Content to export